Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Aerocrine AB · Predicate Candidate Screening
6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
141 daysmedian FDA review time
321 days90th percentile
6clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K150233 | NIOX VERO Airway Inflammation Monitor | Aerocrine AB | 2015-02-26 | 24 | 0 |
| K133898 | NIOX VERO AIRWAY INFLAMMATION MONITOR | Aerocrine AB | 2014-11-06 | 321 | 0 |
| K123683 | NIOX PANEL FOR USE WITH THE NIOX MINO AIRWAY INFLAMMATION MO | Aerocrine AB | 2012-12-27 | 27 | 0 |
| K101034 | NIOX MINO MODEL 09-1000 | Aerocrine AB | 2010-09-02 | 141 | 0 |
| K072816 | NIOX MINO | Aerocrine AB | 2008-03-03 | 153 | 0 |
| DEN030001 | NIOX ARTICLE NO: 02-1000 | Aerocrine AB | 2003-04-30 | 43 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda